Post-earnings recap
Reported
Thu, May 9, 2024
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CorMedix reported a loss per share that was slightly better than expected, but there was no revenue reported. The stock fell by over 5% in response, indicating investor disappointment, likely due to the lack of revenue information and guidance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.25 | N/A | +7.41% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.